Rare Victory For Generic Drug Industry In Patent Ruling
Pharmaceutical giant AstraZeneca has lost a key U.S. court ruling concerning two patents covering the heart drug Toprol-XL in the latest setback in the company's struggle to sustain its pipeline of...To view the full article, register now.
Already a subscriber? Click here to view full article